Comparison between levosimendan versus beta agonists in preservation of renal function in cardiac surgery patients with low cardiac output syndrome

References

• O’Neal J B, Shaw A D and Billings F T IV: Acute kidney injury following cardiac surgery: current understanding and future directions. Critical Care (2016) 20:187
   Google Scholar
• Mehta RL. Acute renal failure and cardiac surgery: marching in place or moving ahead? J Am SocNephrol. 2005;16(1):12–14.
   Web of Science ®Google Scholar
• Vives M Hernandez A Paramon F et al. Acute kidney injury after cardiac surgery: prevalence impact and management challenges. Int J of Nephrology and Renovascular Dis. 2019;12:153–166.
   PubMed Web of Science ®Google Scholar
• Rudiger A Businger F Streit M et al. Presentation and outcome of critically ill medical and cardiac-surgery patients with acute heart failure. Swiss Med Wkly. 2009;139(7–8):110–116. DOI:10.4414/smw.2009.12446
   PubMed Web of Science ®Google Scholar
• Kastrup M Markewitz A Spies C et al. Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: results from a postal survey. ActaAnaesthesiol Scand. 2007;51(3):347–358. DOI:10.1111/j.1399-6576.2006.01190.x
   PubMed Web of Science ®Google Scholar
• Escalona-Belmonte J Rodríguez-Capitán MJ Guerrero-Orriach JL et al. Levosimendan and organic protection. Glob AnaesthPerioper Med. 2016;1:40–45.
   Google Scholar
• Orriach Guerrero JL Ramirez Fernandez A Iglesias P et al. Preoperative levosimendan. A new way for organoprotection. Curr Pharm Des. 2014;20(34):5476–5483. DOI:10.2174/1381612820666140325121452
   PubMed Web of Science ®Google Scholar
• Guerrero-Orriach JL Ariza-Villanueva D Florez-Vela A et al. Cardiac renal and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase. TherClin Risk Manag. 2016;12:623–630.
   PubMed Web of Science ®Google Scholar
• Guerrero OJ Navarro Arce I Hernandez Rodriguez P et al. Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists. BMC Anesthesiol. 2019;19(1):212. doi: 10.1186/s12871-019-0888-2. 01061469692n.
   PubMed Web of Science ®Google Scholar
• Zafari AM. What is Killip classification system & how it used in acute MI. Medscape.com. 2019.
   Google Scholar
• Palevsky PM. Definition & staging criteria of acute kidney injury in adults. Uptodate.com. 2021.
   Google Scholar
• Ding WJ Ji Q Shi YQ et al. Predictors of low cardiac output syndrome after isolated coronary artery bypass grafting. Int Heart J. 2015;56(2):144–149.
   PubMed Web of Science ®Google Scholar
• Chen X Xu J Li Y et al. The effect of postoperative fluid balance on the occurrence and progression of Acute Kidney Injury after cardiac surgery. J Cardiothorac Vasc Anesth. 2021;35(9):35)2700–2706.
   Web of Science ®Google Scholar
• Koster G Wetterslev J Gluud C et al. Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis. Intensive care Med. 2015;41(2):203–221. DOI:10.1007/s00134-014-3604-1
   PubMed Web of Science ®Google Scholar
• Bragadottir G Redfors B Ricksten SE. Effects of levosimendan on renal blood flow glomerular filtration rate renal oxygen consumption and oxygenation after cardiac surgery: a randomized controlled study. Crit Care Med. 2013;41(10):2328–2335.
   PubMed Web of Science ®Google Scholar
• Levin RL Degrange MA Del Maz C et al. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol. 2012;17(3):125–130.
   PubMedGoogle Scholar
• Baysal A Yanartas M Dogukan M et al. Levosimendan improves renal outcome in cardiac surgery: a randomized trial. J Cardiothorac Vasc Anesth. 2014;28(3):586–594. DOI:10.1053/j.jvca.2013.09.004
   PubMed Web of Science ®Google Scholar
• Balzer F Treskatsch S Spies C et al. Early administration of levosimendan is associated with improved kidney function after cardiac surgery – a retrospective analysis. J Cardiothorac Surg. 2014;9(1):167. DOI:10.1186/s13019-014-0167-8
   PubMedGoogle Scholar
• Treskatsch S Balzer F Geyer T et al. Early levosimendan administration is associated with decreased mortality after cardiac surgery. J Crit Care. 2015;30(4):859. DOI:10.1016/j.jcrc.2015.03.008
   Web of Science ®Google Scholar
• Mehta RH Leimberger JD van Diepen S et al. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med. 2017;376(21):2032–2042. DOI:10.1056/NEJMoa1616218
   PubMed Web of Science ®Google Scholar
• Landoni G, Lomivorotov V, Alvaro G,Lobregli R, Pisano A, Guarracino F, Calabrò MG, Grigoryev E V, Likhvantsev V V, Salgado-Filho M F, Bianchi A, Pasyuga V V, et al. for the CHEETAH Study Group: Levosimendan for Hemodynamic Support after Cardiac Surgery. N Engl J Med. 2017;376:2021–2031.
   PubMed Web of Science ®Google Scholar